Aurora Cannabis

Medical Marijuana Market to grow by $ 27.72 bn during 2021-2025, Aphria Inc. and Aurora Cannabis Inc. emerge as Key Contributors to growth| Technavio

Retrieved on: 
Monday, April 26, 2021

b"NEW YORK, April 26, 2021 /PRNewswire/ -- Technavio has monitored themedical marijuana marketin its latest market research report.

Key Points: 
  • b"NEW YORK, April 26, 2021 /PRNewswire/ -- Technavio has monitored themedical marijuana marketin its latest market research report.
  • Aphria Inc., Aurora Cannabis Inc., Cannabis Sativa Inc., Canopy Growth Corp., Cronos Group Inc., DEMECAN Holding GmbH, GW PharmaceuticalsPlc, Medical Marijuana Inc., Tilray Inc., and VIVO Cannabis Inc. are some of the major market participants.
  • The plans to increase the production and availability of medical marijuana by governments will offer immense growth opportunities.
  • In a bid to help players strengthen their market foothold, this medical marijuana marketforecast report provides a detailed analysis of the leading market vendors.

Law Enforcement Concerns Arise Amidst Sweeping Cannabis Legalization

Retrieved on: 
Thursday, April 15, 2021

A Gallup poll from earlier in November showed that a record 68% of Americans support legalizing cannabis, up from 60% in 2016.

Key Points: 
  • A Gallup poll from earlier in November showed that a record 68% of Americans support legalizing cannabis, up from 60% in 2016.
  • Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Planet 13 Holdings Inc. (OTC: PLNHF), Aurora Cannabis Inc. (NYSE: ACB), Tilray, Inc. (NASDAQ: TLRY), HEXO Corp. (NYSE: HEXO)\nHowever, the growing popularity of cannabis raises some regulation concerns.
  • In fact, one of the major concerns over cannabis abuse revolves around operating a vehicle while impaired.
  • Generally, law enforcement officers may conduct field tests such as sobriety tests or even sample tests.

Law Enforcement Concerns Arise Amidst Sweeping Cannabis Legalization

Retrieved on: 
Thursday, April 15, 2021

A Gallup poll from earlier in November showed that a record 68% of Americans support legalizing cannabis, up from 60% in 2016.

Key Points: 
  • A Gallup poll from earlier in November showed that a record 68% of Americans support legalizing cannabis, up from 60% in 2016.
  • Cannabix Technologies Inc. (OTC: BLOZF) (CSE: BLO), Planet 13 Holdings Inc. (OTC: PLNHF), Aurora Cannabis Inc. (NYSE: ACB), Tilray, Inc. (NASDAQ: TLRY), HEXO Corp. (NYSE: HEXO)\nHowever, the growing popularity of cannabis raises some regulation concerns.
  • In fact, one of the major concerns over cannabis abuse revolves around operating a vehicle while impaired.
  • Generally, law enforcement officers may conduct field tests such as sobriety tests or even sample tests.

High Tide Files Preliminary Base Shelf Prospectus

Retrieved on: 
Friday, April 9, 2021

CALGARY, AB, April 8, 2021 /PRNewswire/ -High Tide Inc. ("High Tide" or the "Company") (TSXV: HITI) (OTCQB: HITIF) (FRA:2LY), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce that it has filed a preliminary short form base shelf prospectus (the "Prospectus") to provide the Company with the flexibility to take advantage of financing opportunities and favourable market conditions, if and when needed, during the 25-month period that the Prospectus, once made final, remains effective (the "Effective Period").

Key Points: 
  • CALGARY, AB, April 8, 2021 /PRNewswire/ -High Tide Inc. ("High Tide" or the "Company") (TSXV: HITI) (OTCQB: HITIF) (FRA:2LY), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, is pleased to announce that it has filed a preliminary short form base shelf prospectus (the "Prospectus") to provide the Company with the flexibility to take advantage of financing opportunities and favourable market conditions, if and when needed, during the 25-month period that the Prospectus, once made final, remains effective (the "Effective Period").
  • The Prospectus has been filed in each of the provinces and territories in Canada.
  • High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories.
  • Key industry investors in High Tide include Aphria Inc. (TSX:APHA) (NYSE:APHA) and Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB).

Canopy Growth to Acquire The Supreme Cannabis Company

Retrieved on: 
Thursday, April 8, 2021

TORONTO, and SMITH FALLS, ON, April 8, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy") (TSX: WEED) (NASDAQ: CGC) and The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or "Supreme") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") under which Canopy will acquire all of Supreme Cannabis' issued and outstanding common shares (the "Supreme Cannabis Shares") in a transaction valued at approximately $435million on a fully-diluted basis (the "Transaction").

Key Points: 
  • TORONTO, and SMITH FALLS, ON, April 8, 2021 /PRNewswire/ - Canopy Growth Corporation ("Canopy") (TSX: WEED) (NASDAQ: CGC) and The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or "Supreme") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") under which Canopy will acquire all of Supreme Cannabis' issued and outstanding common shares (the "Supreme Cannabis Shares") in a transaction valued at approximately $435million on a fully-diluted basis (the "Transaction").
  • The Transaction provides Supreme Cannabis shareholders with a premium per Supreme Cannabis Share of approximately 66% based on the closing prices of the Supreme Cannabis Shares and Canopy common shares on the Toronto Stock Exchange (the "TSX") as of April 7, 2021.
  • Secures an immediate attractive premium for Supreme Cannabis shareholders: The Transaction provides Supreme Cannabis shareholders with a premium per Supreme Cannabis Share of approximately 66% based on the closing prices of the Supreme Cannabis Shares and Canopy common shares on the TSX as of April 7, 2021.
  • The Transaction was approved by the board of directors of each of Canopy and Supreme Cannabis, and Supreme Cannabis' board of directors recommends that Supreme Cannabis shareholders vote in favour of the Transaction.

High Tide Extends Maturity Date and Reduces Interest Rate of Convertible Debt with Strategic Partner

Retrieved on: 
Thursday, April 8, 2021

"I am very pleased to report that this strategic partner has agreed to extend this debenture," said Raj Grover, President & Chief Executive Officer of High Tide.

Key Points: 
  • "I am very pleased to report that this strategic partner has agreed to extend this debenture," said Raj Grover, President & Chief Executive Officer of High Tide.
  • "During the past nine months, we have now announced that four lenders to High Tide have agreed to extend the maturity of their debt by more than one year and simultaneously cut the applicable interest rate and this encompasses $42 million in total facilities.
  • High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories.
  • Key industry investors in High Tide include Aphria Inc. (TSX:APHA) (NYSE:APHA) and Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB).

Medical Cannabis by Shoppers Drug Mart, Inc. Expands Patient Offering with Mera’s Suite of Ellevia Products

Retrieved on: 
Tuesday, March 2, 2021

Ellevia medical cannabis products include oils, topicals and flower all designed with the patient in mind.

Key Points: 
  • Ellevia medical cannabis products include oils, topicals and flower all designed with the patient in mind.
  • ST. THOMAS, Ontario, March 02, 2021 (GLOBE NEWSWIRE) -- Mera Cannabis Corp. (Mera) is pleased to announce the launch of its Ellevia medical cannabis brand and product line through a supply agreement with Medical Cannabis by Shoppers Inc., a subsidiary of Shoppers Drug Mart Inc. Products are now available to medical cannabis patients who are registered through the Medical Cannabis by Shoppers marketplace.
  • We know the team at Medical Cannabis by Shoppers will only strengthen our offering to patients, as a trusted household name in the industry.
  • Mera is focused on producing consumer-driven, high-value cannabis products at its EU GMP-built cultivation and processing facility inSt Thomas, Ontario.

LYPHE Group imports Northern Green Canada into the U.K. market as supply to the medical cannabis brand, NOIDECS

Retrieved on: 
Wednesday, February 17, 2021

The growing range of NOIDECS products is welcome news for the U.K. market, which has historically struggled with consistent supply of flower-based medical cannabis products.

Key Points: 
  • The growing range of NOIDECS products is welcome news for the U.K. market, which has historically struggled with consistent supply of flower-based medical cannabis products.
  • It also adds to the long line of products stocked by LYPHE Group pharmacy, Dispensary Green, which stocks more than 90% of all available brands in the market.
  • Lisa McCormack, CEO, Northern Green Canada said in response: "We are delighted to support LYPHE Group as they build their NOIDECS range into a mainstay of the U.K. and European markets.
  • LYPHE is comprised of the following industry leading companies:
    About Northern Green Canada Inc.
    Northern Green Canada Inc. is a federally licensed, EU GMP-certified producer of medical cannabis, focused on providing cannabis medications for a better quality of life.

LYPHE Group imports Northern Green Canada into the U.K. market as supply to the medical cannabis brand, NOIDECS

Retrieved on: 
Wednesday, February 17, 2021

The growing range of NOIDECS products is welcome news for the U.K. market, which has historically struggled with consistent supply of flower-based medical cannabis products.

Key Points: 
  • The growing range of NOIDECS products is welcome news for the U.K. market, which has historically struggled with consistent supply of flower-based medical cannabis products.
  • It also adds to the long line of products stocked by LYPHE Group pharmacy, Dispensary Green, which stocks more than 90% of all available brands in the market.
  • Lisa McCormack, CEO, Northern Green Canada said in response: "We are delighted to support LYPHE Group as they build their NOIDECS range into a mainstay of the U.K. and European markets.
  • LYPHE is comprised of the following industry leading companies:
    About Northern Green Canada Inc.
    Northern Green Canada Inc. is a federally licensed, EU GMP-certified producer of medical cannabis, focused on providing cannabis medications for a better quality of life.

Global CBD Consumers Continue to Gain More Offerings as Market Regulations Around the World Solidify

Retrieved on: 
Wednesday, February 17, 2021

A new bipartisan bill is currently being reintroduced to the US congress , while the European CBD market is already projected to grow 400% through 2023.

Key Points: 
  • A new bipartisan bill is currently being reintroduced to the US congress , while the European CBD market is already projected to grow 400% through 2023.
  • "Global consumers are becoming increasingly familiar with CBD and its potential benefits to their daily routine," added Dr. Mitchell.
  • "After conducting months of extensive consumer research, it was clear that the majority of our customers and consumers in the market are seeking products with increased CBD percentages.
  • Last year, Aurora Cannabis (NYSE:ACB) (TSX:ACB) made headlines when it made a CBD deal to enter the lucrative US market.